Global Osteoarthritis Therapy Market Outlook



Dublin, October 26, 2021 (GLOBE NEWSWIRE) – The report “Osteoarthritis Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunities and Forecast 2021-2026” has been added to offer.

The global osteoarthritis treatment market reached a value of nearly US $ 8 billion in 2020. Going forward, the market is expected to grow at a CAGR of 8.4% during the period 2021-2026. Bearing in mind the uncertainties of COVID-19, the analyst is continuously monitoring and evaluating the direct and indirect influence of the pandemic. This information is included in the report as a major contributor to the market.

Osteoarthritis (OA) is a heterogeneous disease characterized by progressive degeneration of the cartilage in the joints of the knees, hips, hands, feet, spine, shoulders and neck. Osteoarthritis usually results in stiffness, swelling, tenderness, persistent pain, loss of flexibility, a squeaky sensation, bone spurs, and trouble sleeping. It can be diagnosed using a physical exam, x-ray, arthroscopy, joint fluid analysis, blood tests, and magnetic resonance imaging (MRI). Various medications and surgeries are prescribed depending on the different outcome to relieve the signs and symptoms of the disease. Currently, alternative medicine, physical therapy, and supportive devices are available on the market to relieve pain and improve joint function.

Global Osteoarthritis Therapy Market Trends and Drivers

Sedentary lifestyles, unhealthy eating habits, and the increasing prevalence of obesity and blood sugar levels increase the risk of developing osteoarthritis in individuals. This, in confluence with the growing geriatric population, which is more susceptible to such diseases, represents one of the key factors driving the growth of the osteoarthritis treatments market. Apart from that, easy access to MRI scans acts as another major growth factor. Moreover, the development of imaging biomarkers based on radiographic characteristics, coupled with the introduction of analgesic drugs, is contributing to the growth of the market. In addition, increasing investments in research and development (R&D) activities to launch new diagnostics and biomarkers, as well as increasing spending on improving health infrastructure, are also driving the market. For example, disease-modifying drugs are under development that focus on pro-inflammatory cytokines to treat cartilage degradation.

Key market segmentation

The analyst provides key trend analysis in each sub-segment of the global osteoarthritis treatment market, along with forecast at global, regional, and country level from 2021 to 2026. The report categorized the market on the basis of region, type of anatomy, type of drug, route of administration and channel of delivery.

Rupture by anatomy type

Breakdown by drug type

  • Nonsteroidal anti-inflammatory drugs
  • Pain relievers
  • Corticosteroids
  • Others

Breakdown by route of administration

Breakdown by distribution channel

  • Hospitals
  • Specialized clinics
  • Medical institutions
  • Others

Breakdown by region

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive landscape

The report also analyzed the competitive landscape of the market with some of the major players being Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly and Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc.. , Pfizer Inc. and Sanofi SA

Key questions answered in this report

  • How has the global osteoarthritis treatments market performed so far and how will it perform in the years to come?
  • What has been the impact of COVID-19 on the global osteoarthritis therapy market?
  • What are the main regional markets?
  • What is the market split according to the type of anatomy?
  • What is the market split according to the type of drug?
  • What is the market split according to the route of administration?
  • What is the distribution of the market according to the distribution channel?
  • What are the different stages of the industry value chain?
  • What are the main factors and challenges for the industry?
  • What is the structure of the global osteoarthritis therapy market and who are the major players?
  • How competitive is the industry?

Main topics covered:

1 Preface

2 Scope and methodology

3 Executive summary

4 Presentation
4.1 Overview
4.2 Key Industry Trends

5 Global Osteoarthritis Therapy Market
5.1 Market overview
5.2 Market performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market breakdown by anatomy type
6.1 Knee
6.1.1 Market trends
6.1.2 Market Forecast
6.2 Hip
6.2.1 Market trends
6.2.2 Market Forecast
6.3 Hand
6.3.1 Market trends
6.3.2 Market Forecast
6.4 Spine
6.4.1 Market trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market trends
6.5.2 Market Forecast

7 Market breakdown by type of drug
7.1 Nonsteroidal anti-inflammatory drugs
7.1.1 Market trends
7.1.2 Market Forecast
7.2 Analgesics
7.2.1 Market trends
7.2.2 Market Forecast
7.3 Corticosteroids
7.3.1 Market trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market trends
7.4.2 Market Forecast

8 Market distribution by administration
8.1 Parenteral
8.1.1 Market trends
8.1.2 Market Forecast
8.2 Topical
8.2.1 Market trends
8.2.2 Market Forecast
8.3 Oral
8.3.1 Market trends
8.3.2 Market Forecast

9 Market breakdown by distribution channel
9.1 Hospitals
9.1.1 Market trends
9.1.2 Market Forecast
9.2 Specialized clinics
9.2.1 Market trends
9.2.2 Market Forecast
9.3 Medical facilities
9.3.1 Market trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market trends
9.4.2 Market Forecast

10 Market breakdown by region

11 SWOT Analysis

12 Value chain analysis

13 Porters Five Forces Analysis

14 Price analysis

15 Competitive landscape
15.1 Market structure
15.2 Key players
15.3 Profiles of key players
15.3.1 Abbott Laboratories Company presentation Product portfolio Finances SWOT Analysis
15.3.2 Anika Therapeutics Inc. Company overview Product portfolio Finances SWOT Analysis
15.3.3 Bayer Aktiengesellschaft Company overview Product portfolio Finances SWOT Analysis
15.3.4 Eli Lilly and Company Company overview Product portfolio Finances SWOT Analysis
15.3.5 Flexion Therapeutics Inc. Company overview Product portfolio Finances
15.3.6 GlaxoSmithKline API Company overview Product portfolio Finances SWOT Analysis
15.3.7 Horizon Therapeutics PLC Company overview Product portfolio Finances SWOT Analysis
15.3.8 Johnson & Johnson Inc. Company overview Product portfolio Finances SWOT Analysis
15.3.9 Pfizer Inc. Company overview Product portfolio Finances SWOT Analysis
15.3.10 Sanofi SA Company overview Product portfolio Finances SWOT Analysis

For more information on this report, visit


Leave A Reply

Your email address will not be published.